Stories

Topic's Include: Hospital visitor restrictions to begin Jan. 3, 2022 in Rochester and Mayo Clinic Q and A: Children and video games.

This week’s research roundup features: Risk of late-onset breast cancer in genetically predisposed women.

Topic's Include: Reinfection rates of omicron and why people need to take this seriously, Mayo Clinic Q&A podcast: COVID-19 pandemic highlights health disparities, and the types of COVID-19 tests and when to use them.

This week’s research roundup features: Learning through a Pandemic: The current state of knowledge on COVID-19 and cancer.

Topic's Include: Mayo Clinic expert discusses the latest on omicron variant, one year of COVID-19 vaccines at Mayo Clinic, and predictive modeling for COVID in preparation for the holiday travel season.

Recipient of a young investigator award from the American Association of Clinical Chemistry, Dr. Maria Alice Willrich’s work has been crucial in advancing therapeutic drug monitoring to improve outcomes for patients with inflammatory bowel disease.

This week’s research roundup features: Renal Neoplasia in Polycystic Kidney Disease: An assessment of Tuberous Sclerosis complex-associated Renal Neoplasia and PKD1/TSC2 contiguous gene deletion syndrome.

Topic's Include: Mayo Clinic scientist explains genome sequencing of SARS-CoV-2, taking a closer look at the omicron and delta variants, and testing for COVID-19 at home.

This week’s research roundup features: The management of cancer symptoms and treatment-induced side effects with cannabis or cannabinoids.

The quest to create a test pinpointing the source of the rare, testicular cancer-associated illness successfully concluded in the summer of 2021.

Starting December 7, you will notice enhancements to MayoClinicLabs.com. We are building a better website for you, our clients, to ensure the best experience possible. We’re moving toward a simpler, more intuitive and customized experience, making it easier to do business with us. 

Topic's Include: Mayo Clinic Q&A podcast: Boosters reduce vulnerability to COVID-19 variants, what Mayo experts know about the omicron variant, and mental health and the holidays: Resilience.

While Gregor Heinrich never could have imagined that testicular cancer was related to his problems with his vision and gait, learning he was positive for KLHL11 protein biomarkers meant he could receive treatment for both the cancer and the illness behind it.